YLYan Li

Yan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yan Li has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Cao Ma

    Department of Pathology, Zhongda Hospital, School of Medicine Southeast University Nanjing China

    1 shared publication
  • Chenqi Xu

    Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, 200032, PR China; Kidney and Dialysis Institute of Shanghai, Shanghai, 200032, PR China; Shanghai Medical Center for Kidney Diseases, Shanghai, 200032, PR China; Shanghai Key Laboratory for Kidney Diseases and Blood Purification, Shanghai, 200032, PR China

    1 shared publication
  • Claudio Ronco

    International Renal Research Institute of Vicenza (IRRIV), Vicenza, Italy

    1 shared publication
  • Haiyu Tang

    Department of Cardiovascular, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital Central China Fuwai Hospital of Zhengzhou University Henan 450003 P. R. China

    1 shared publication
  • Jiaqi Gu

    Arizona State University

    1 shared publication
  • Kang Zhao

    Department of Cardiovascular, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital Central China Fuwai Hospital of Zhengzhou University Henan 450003 P. R. China

    1 shared publication

Latest Publications

  • Evaluation of an Injectable Hydrogel Based on Hyaluronic Acid–Chitosan/β‐Glycerophosphate‐Loaded Mesenchymal Stem Cells in Enhancing the Therapeutic Efficacy of Myocardial Infarction

    by Liang Peng, Muwei Li, Kang Zhao, Cao Ma, Haiyu Tang, Yan Li

    Myocardial infarction (MI), which is due to cardiac dysfunction, results in morbidity and mortality. Moreover, the cellular activity of transplanted mesenchymal stem cells (MSCs) generally limits their therapeutic efficacy in the treatment of MI. Here, inject able hyaluronic acid‐chitosan/β‐glycerophosphate (HA–CS/β‐GP) hydrogel‐loaded MSCs are prepared, after which their effects on the treatment of MI are investigated. The synthesized HA–CS/β‐GP hydrogels exhibit swelling ratio, an in vitro degradation value, and a gelatin time of 82.19 ± 4.1, 88.18% ± 2.4%, and 9 s, respectively. Further, rheological studies revealed that the elastic modulus of the HA–CS/β‐GP hydrogels is ≥230 Pa, exhibiting large elastic to viscous modulus ratio, which indicates their mechanical strength. Furthermore, the in vitro 3T3 cell and MSC culture studies confirm the good biocompatibility of the HA–CS and HA–CS/β‐GP hydrogels. The implantation of the synthesized hydrogels in the mouse MI model considerably improves the therapeutic effect of the MSCs (enhanced cardiac function, reduced cardiomyocyte apoptosis, and increased vascularization) for the first time. The innovative synergistic strategy of combining injectable HA–CS and HA–CS/β‐GP hydro gels with MSCs may be suitable for the effective treatment of cardiac morbidity due to MIs.


  • The Incidence Prognosis and Risk Factors of Cognitive Impairment in Maintenance Haemodialysis Patients

    by Renhua Lu, Chenqi Xu, Yan Li, Ling Yu, Xinghua Shao, Kewei Xie, Jiaqi Gu, Zanzhe Yu, Yucheng Yan, Yangtai Guan, et al.

    Objective: To investigate the incidence and the prognosis of cognitive impairment (CI) and to find out the risk factors associated with the outcome in maintenance haemodialysis (MHD) patients. Methods: Enrolled the patients who met the criteria as below: MHD (≥3 months) patients before July 2014, ≥18 years old and could carry on the cognitive function test (Montreal Cognitive Assessment [MoCA]). All enrolled patients were divided into 2 groups: CI group (MoCA < 26) and non-CI group (MoCA ≥26). All patients were followed up for 36 months. The incidence, demography data, medical history, haemodialysis data, laboratory examination and prognosis of CI in haemodialysis patients were prospectively compared and analyzed. Multivariate logistic regression analysis was used to investigate the risk factors of CI. Kaplan-Meier survival curve was used for survival analysis. Results: In the present study, 219 patients were enrolled. The ratio of male to female was 1.46: 1. Age was 60.07 ± 12.44 and dialysis vintage was 100.79 ± 70.23 months. One hundred thirteen patients’ MoCA scores were lower than 26 were divided into CI group. Education status (OR 3.428), post-dialysis diastolic pressure (OR 2.234) and spKt/V (OR 1.982) were independent risk factors for CI in MHD patients. During the follow-up period, 15 patients died (13.2%) in the CI group and 5 died (4.72%) in the non-CI group (p < 0.05). The Kaplan-Meier survival curve analysis showed that the survival rate of patients with CI was lower than that of non-CI group in MHD patients during 3 years follow-up (p = 0.046). Conclusion: CI is one of the most common complications in MHD patients. The mortality is high in patients who had CI. Education status, post-dialysis diastolic pressure and spKt/V are independent risk factors for CI in MHD patients.